Edwards Lifesciences (EW): Politician trade (House)

$1,001–$15,000
Reported range · official band, not an exact amount: 40 days
Disclosure lag

Traded: Nov 19, 2025
Disclosed: Dec 29, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Sep 23, 2025FDAFDA device clearance: Edwards MC3 Tricuspid annuloplasty ring (4900)
Oct 17, 20255% stakeBlackRock, Inc. reported a passive stake (13G) of 7.5%
Oct 21, 2025FDAFDA device clearance: HemoSphere Stream Module
Oct 30, 2025Company filing · Form 8-K · ResultsReported its results
Oct 30, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On October 30, 2025, Scott Ullem, the Chief Financial Officer of Edwards Lifesciences Corporation, a Delaware corporation (the “Corporation”), informed the Corporation of his decision to transition from his role by mid-year 2026.”
Nov 10, 2025Insider · 2 peopleInsiders: 3 sales (~$1.2M)
Nov 19, 2025 · this disclosureCongressDisclosed sale of EW — reported range $1,001 - $15,000

What came next

Dec 8, 2025Insider · 2 peopleInsiders: 2 sales (~$1.9M)
Dec 9, 2025InsiderCFO sold ~$650K of EW shares in the open market
Dec 10, 2025Insider · 2 peopleInsiders: 2 sales (~$1.3M)
Dec 11, 2025InsiderOfficer sold ~$169K of EW shares in the open market
Dec 12, 2025Insider · 3 peopleInsiders: 4 sales (~$1.3M)
Dec 18, 2025FDAFDA device clearance: HemoSphere Alta Advanced Monitoring Platform (ALTAALL1; ALTACR1; ALTASR1)
Dec 22, 2025FDAFDA device approval: SAPIEN M3 Transcatheter Mitral Valve Replacement System
Jan 6, 2026Insider · 1 personInsiders: 2 sales (~$971K)
Jan 9, 2026InsiderOfficer sold ~$87K of EW shares in the open market
Feb 10, 2026Company filing · Form 8-K · ResultsReported its results
Feb 12, 2026Insider · 1 personInsiders: 2 sales (~$1.7M)
Feb 24, 2026FDAFDA device clearance: HemoSphere Nano Monitor (HSNANO1)
Feb 25, 2026InsiderOfficer sold ~$2.01M of EW shares in the open market
Mar 2, 2026InsiderOfficer sold ~$974K of EW shares in the open market
Mar 11, 2026Insider · 2 peopleInsiders: 3 sales (~$1.2M)

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Edwards Lifesciences

For Edwards Lifesciences, OQRO holds 11 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 21 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EW page.

Other recent filings by Rep. Josh Gottheimer (NJ05)

The full history of Rep. Josh Gottheimer (NJ05) is on the profile page.

Other disclosures at Edwards Lifesciences

Everything OQRO holds on this company is on its EW page.

Edwards Lifesciences (EW)Rep. Josh Gottheimer (NJ05) disclosed a sale $1K–$15K